Form 4: Replimune Group Executive Chairman Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Philip Astley-Sparke, Executive Chairman of Replimune Group, sold 37,928 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On May 16, 2024, Philip Astley-Sparke, the Executive Chairman of Replimune Group, Inc., sold 37,928 shares of the company's common stock.
- The sale was executed to cover tax withholding obligations associated with the partial vesting of his restricted stock units (RSUs).
- The shares were sold at a weighted average price of $6.47, with individual transactions ranging from $6.46 to $6.55 per share.
- Following the transaction, Astley-Sparke still beneficially owns 1,487,350 shares of Replimune Group, Inc.
- The sale was conducted according to an irrevocable 'sell to cover' provision in the RSU award agreements, indicating it was not a discretionary sale.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't necessarily reflect a change in the executive's outlook on the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives. This transaction is not necessarily indicative of the executive's sentiment towards the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 05/16/2024 | Date of the transaction: Philip Astley-Sparke sold shares of Replimune Group, Inc. |
| 05/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.